A fresh, new approach to diseases like Alzheimer’s.
We’ve come to realize that our best chances of success lie in preventative measures for larger populations that may be at-risk, don’t present with symptoms – yet. Our team has pioneered innovative approaches to recruit and retain these individuals. And we’ve developed the industry’s deepest knowledgebase to find investigators with the highest chances of success.
From science to synapse.
Our team is made up of experts in the specialty of neuroscience and neurologists – spanning both R&D and clinical. We’ll help you integrate the nonclinical science into the clinical development phases for translatability and issue resolution throughout the development process.
Effective strategies that keep the patient in mind.
Understandably, the entire field of neuroscience is highly sensitive to risks that arise from non-compliance, controlled substance abuse and psychological instability. We utilize our deep investigator network and comprehensive training tactics to gather quality data across geographies. And we continually innovate in more empirical measures through biomarkers and imaging to ease the burden on patients.
Inter-connected services across related diseases.
We deliver a holistic suite of services for your neuroscience development. It starts with nonclinical pharmacology and toxicology scientists who are thought leaders in this rapidly changing field. Add to that a wide array of biomarker and antibody products specific to neuroscience, along with core phase I-IV development and testing services around the globe. And, we integrate our commercialization services early in the process to maximize your ROI in the real world. Our flexible menu of services include: